Literature DB >> 15721355

Use of chimeric adenoviral vectors to assess capsid neutralization determinants.

Soumitra Roy1, David S Clawson, Roberto Calcedo, Corinna Lebherz, Julio Sanmiguel, Di Wu, James M Wilson.   

Abstract

In order to elucidate the relative importance of neutralizing determinants on each of the three major adenoviral capsid components, we have generated chimeric vectors where the hexon protein, or the fiber protein, or both hexon and fiber proteins of one serotype (Simian Adenovirus 24/Pan 7) have been replaced by those of another (Simian Adenovirus 23/Pan 6). The effect of each replacement was evaluated by neutralization assays and by attempted vector re-administration into mice. Both hexon and fiber were found to harbor neutralization epitopes although in vivo transduction was more severely affected by anti-hexon antibodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15721355     DOI: 10.1016/j.virol.2004.12.029

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity.

Authors:  Anja Krause; Ju H Joh; Neil R Hackett; Peter W Roelvink; Joseph T Bruder; Thomas J Wickham; Imre Kovesdi; Ronald G Crystal; Stefan Worgall
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Structure-based identification of a major neutralizing site in an adenovirus hexon.

Authors:  Susan L Pichla-Gollon; Mark Drinker; Xiangyang Zhou; Feng Xue; John J Rux; Guang-Ping Gao; James M Wilson; Hildegund C J Ertl; Roger M Burnett; Jeffrey M Bergelson
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

3.  Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.

Authors:  Susan L Pichla-Gollon; Shih-Wen Lin; Scott E Hensley; Marcio O Lasaro; Larissa Herkenhoff-Haut; Mark Drinker; Nia Tatsis; Guang-Ping Gao; James M Wilson; Hildegund C J Ertl; Jeffrey M Bergelson
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

4.  Directed evolution of mutator adenoviruses resistant to antibody neutralization.

Authors:  Nicolle D Myers; Ksenia V Skorohodova; Anshu P Gounder; Jason G Smith
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

5.  Molecular evolution of human adenovirus type 16 through multiple recombination events.

Authors:  Xingui Tian; Hongkai Wu; Rong Zhou
Journal:  Virus Genes       Date:  2019-08-05       Impact factor: 2.332

Review 6.  Adenovirus.

Authors:  Jason G Smith; Christopher M Wiethoff; Phoebe L Stewart; Glen R Nemerow
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization.

Authors:  Jason G Smith; Mariena Silvestry; Steffen Lindert; Wuyuan Lu; Glen R Nemerow; Phoebe L Stewart
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

8.  Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5.

Authors:  Shinya Abe; Kenji Okuda; Takehiro Ura; Asami Kondo; Atsushi Yoshida; Shinji Yoshizaki; Hiroyuki Mizuguchi; Dennis Klinman; Masaru Shimada
Journal:  J Gene Med       Date:  2009-07       Impact factor: 4.565

9.  Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport.

Authors:  Jason G Smith; Aurelia Cassany; Larry Gerace; Robert Ralston; Glen R Nemerow
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

Review 10.  Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.

Authors:  Estrella Lopez-Gordo; Iva I Podgorski; Nicholas Downes; Ramon Alemany
Journal:  Hum Gene Ther       Date:  2014-03-25       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.